Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Betsy J. Bernard net worth and biography

Betsy Bernard Biography and Net Worth

Director of Zimmer Biomet

President of AT&T Corp. from October 2002 until her retirement in December 2003. From April 2001 to October 2002, Ms. Bernard was Chief Executive Officer of AT&T Consumer. Prior to joining AT&T, Ms. Bernard held senior executive positions with Qwest Communications International Inc., US WEST, Inc., AVIRNEX Communications Group and Pacific Bell. Ms. Bernard received a B.A. degree from St. Lawrence University, an MBA from Fairleigh Dickenson University and an M.S. in management from Stanford University’s Sloan Fellowship Program.

What is Betsy J. Bernard's net worth?: The estimated net worth of Betsy J. Bernard is at least $17,902.50 as of March 20th, 2023. Ms. Bernard owns 150 shares of Zimmer Biomet stock worth more than $17,903 as of April 27th. This net worth estimate does not reflect any other assets that Ms. Bernard may own. Learn More about Betsy J. Bernard's net worth.
How do I contact Betsy J. Bernard?: The corporate mailing address for Ms. Bernard and other Zimmer Biomet executives is 345 EAST MAIN STREET, WARSAW IN, 46580. Zimmer Biomet can also be reached via phone at (574) 267-6131 and via email at [email protected]. Learn More on Betsy J. Bernard's contact information.
Has Betsy J. Bernard been buying or selling shares of Zimmer Biomet?: Betsy J. Bernard has not been actively trading shares of Zimmer Biomet during the past quarter. Most recently, on Monday, March 20th, Betsy J. Bernard bought 150 shares of Zimmer Biomet stock. The stock was acquired at an average cost of $111.89 per share, with a total value of $16,783.50. Following the completion of the transaction, the director now directly owns 150 shares of the company's stock, valued at $16,783.50. Learn More on Betsy J. Bernard's trading history.
Who are Zimmer Biomet's active insiders?: Zimmer Biomet's insider roster includes Betsy Bernard (Director), Wilfred can Zuilen (Insider), Robert Hagemann (Director), Bryan Hanson (CEO), Arthur Higgins (Director), Sreelakshmi Kolli (Director), Michael Michelson (Director), Chad Phipps (VP), and Sang Yi (Insider). Learn More on Zimmer Biomet's active insiders.
Are insiders buying or selling shares of Zimmer Biomet?: During the last year, Zimmer Biomet insiders bought shares 4 times. They purchased a total of 5,300 shares worth more than $619,090.00. During the last year, insiders at the medical equipment provider sold shares 1 times. They sold a total of 26,156 shares worth more than $3,364,184.72. The most recent insider tranaction occured on February, 22nd when VP Chad F Phipps sold 26,156 shares worth more than $3,364,184.72. Insiders at Zimmer Biomet own 1.0% of the company. Learn More about insider trades at Zimmer Biomet.
Information on this page was last updated on 2/22/2024.

Betsy J. Bernard Insider Trading History at Zimmer Biomet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/20/2023	Buy	150	$111.89	$16,783.50	150
2/6/2019	Buy	4,250	$117.41	$498,992.50	2,000

Betsy J. Bernard Buying and Selling Activity at Zimmer Biomet

Zimmer Biomet Company Overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $119.35

$118.66

$119.94

50 Day Range

MA: $125.98

$119.35

$132.61

2 Week Range

Now: $119.35

$102.00

$149.25

Volume

1,099,195 shs

Average Volume

1,046,552 shs

Market Capitalization

$24.52 billion

P/E Ratio

24.41

Dividend Yield

0.80%

Beta

1.01